ENTRADA THERAPEUTICS INC. - COMMON STOCK
7.5000
23-May-25 13:45:00
15 minutes delayed
Stocks
-0.1200
-1.57%
Today's range
7.4200 - 7.7000
ISIN
N/A
Source
NASDAQ
-
Entrada Therapeutics Reports Second Quarter 2022 Financial Results
11 Aug 2022 04:00:02 By Nasdaq GlobeNewswire
-
04 Aug 2022 04:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
19 Jul 2022 04:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at William Blair Biotech Focus Conference
06 Jul 2022 04:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
01 Jun 2022 04:00:02 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2022 Financial Results
12 May 2022 04:00:01 By Nasdaq GlobeNewswire
-
11 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference
10 May 2022 04:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
15 Mar 2022 04:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
23 Feb 2022 05:00:02 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
05 Jan 2022 05:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes
17 Dec 2021 05:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2021 Financial Results
09 Dec 2021 04:00:00 By Nasdaq GlobeNewswire